Vitality Watch

Dossier pubmed review 17-sep-2026
Narrative review or expert overview without new data

Stress and cancer from an integrative psychoneuroimmunology perspective: Neurobiological mechanisms and clinical implications.

Key claim: Chronic psychosocial stress influences cancer incidence, progression, and survival through HPA-axis and sympathetic neuroendocrine–immune mechanisms that impair immunosurveillance, shape the tumor microenvironment, and may accelerate biological aging via cellular senescence and SASP.

Abstract

Growing evidence from preclinical and clinical studies suggests that psychosocial factors, including stress, influence cancer incidence, progression, and survival. From a psychoneuroimmunology perspective, this integrative review synthesizes the neurobiological mechanisms underlying stress-cancer interactions, together with the epidemiological evidence supporting this relationship and its methodological limitations. Chronic stress impairs tumor immunosurveillance by CD8⁺ T cells and natural killer cells through dysregulation of the hypothalamic-pituitary-adrenal axis and sympathetic activation, and promotes angiogenesis and immunosuppression within the tumor microenvironment via β₂-adrenergic receptor signaling downstream of catecholamine release. Chronic exposure to catecholamines and cortisol has also been linked to cellular senescence and a senescence-associated secretory phenotype, raising the possibility that psychological stress contributes to accelerated biological aging in patients with cancer. In addition, individual genetic variability in adrenergic and glucocorticoid receptor signaling, counter-regulatory parasympathetic (vagal) anti-inflammatory pathways, and direct tumor innervation further modulate the magnitude and direction of stress effects on tumor biology. Chronic stress may also promote cancer risk indirectly through health behaviors such as smoking and physical inactivity, mediated by dopaminergic and cytokine-related neurobiological pathways. Together, these multilayered, bidirectional neuro-endocrine-immune mechanisms support viewing distress not merely as a source of psychological discomfort but as a biologically consequential factor in cancer care.

Why this matters

Stress biology is usually walled off from the mechanistic aging picture, but this review pulls chronic HPA-axis and sympathetic signaling into the same senescence/SASP/inflammaging substrate the rest of the area tracks — proposing that psychosocial stress in cancer patients accelerates biological aging through the same nodes senolytic and anti-inflammatory programs target. It broadens the upstream trigger menu for cellular senescence beyond DNA damage, mitochondrial stress, and metabolic insults to include neuroendocrine load, and it flags cancer populations as a testbed where stress → senescence → outcome links might be measurable.

Source

Link

Briefing card

Stress and cancer from an integrative psychoneuroimmunology perspective: Neurobiological mechanisms and clinical implications.
Stage: review · pubmed · 17-sep-2026

If you have a cancer diagnosis or are in survivorship, this review argues chronic stress physiology is a plausible modifier of tumor biology and biological aging, not just a quality-of-life concern — though it does not show that reducing stress changes cancer outcomes.

Chronic psychosocial stress influences cancer incidence, progression, and survival through HPA-axis and sympathetic neuroendocrine–immune mechanisms that impair immunosurveillance, shape the tumor microenvironment, and may accelerate biological aging via cellular senescence and SASP.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.neubiorev.2026.106983

build build 880 · 2bcef25 · 2026-11-18